Search Results - "Adams, Paul T."

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial by Bear, Harry D, Prof, Tang, Gong, PhD, Rastogi, Priya, MD, Geyer, Charles E, Prof, Liu, Qing, PhD, Robidoux, André, Prof, Baez-Diaz, Luis, MD, Brufsky, Adam M, Prof, Mehta, Rita S, Prof, Fehrenbacher, Louis, MD, Young, James A, MD, Senecal, Francis M, MD, Gaur, Rakesh, MD, Margolese, Richard G, MD, Adams, Paul T, MD, Gross, Howard M, MD, Costantino, Joseph P, Prof, Paik, Soonmyung, Prof, Swain, Sandra M, Prof, Mamounas, Eleftherios P, MD, Wolmark, Norman, Prof

“…Summary Background NSABP B-40 was a 3 × 2 factorial trial testing whether adding capecitabine or gemcitabine to docetaxel followed by doxorubicin plus…”
Get full text

North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study by Leal, Alexis D., Qin, Rui, Atherton, Pamela J., Haluska, Paul, Behrens, Robert J., Tiber, Charles H., Watanaboonyakhet, Patanit, Weiss, Matthias, Adams, Paul T., Dockter, Travis J., Loprinzi, Charles L.

“…BACKGROUND Chemotherapy‐induced peripheral neuropathy (CIPN) is a significant side effect of taxane and platinum‐based chemotherapy. Several studies have…”
Get full text

Randomized Trial to Assess the Impact of Venlafaxine and Soy Protein on Hot Flashes and Quality of Life in Men With Prostate Cancer by VITOLINS, Mara Z, GRIFFIN, Leah, SHAW, Edward G, TOMLINSON, W. Vic, VUKY, Jacqueline, ADAMS, Paul T, MOOSE, Dawn, FRIZZELL, Bart, LESSER, Glenn J, NAUGHTON, Michelle, RADFORD, James E

“…Hot flashes occur in approximately 80% of androgen-deprived men. Few intervention studies have been conducted to relieve hot flashes in men. Eligible…”
Get full text

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer by Bear, Harry D, Tang, Gong, Rastogi, Priya, Geyer, Charles E, Robidoux, André, Atkins, James N, Baez-Diaz, Luis, Brufsky, Adam M, Mehta, Rita S, Fehrenbacher, Louis, Young, James A, Senecal, Francis M, Gaur, Rakesh, Margolese, Richard G, Adams, Paul T, Gross, Howard M, Costantino, Joseph P, Swain, Sandra M, Mamounas, Eleftherios P, Wolmark, Norman

“…The addition of bevacizumab to neoadjuvant combination chemotherapy significantly increased the percentage of patients with a pathological complete response…”
Get full text

The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40 by Bear, Harry D., Tang, Gong, Rastogi, Priya, Geyer, Charles E., Zoon, Christine K., Kidwell, Kelley M., Robidoux, André, Baez-Diaz, Luis, Brufsky, Adam M., Mehta, Rita S., Fehrenbacher, Louis, Young, James A., Senecal, Francis M., Gaur, Rakesh, Margolese, Richard G., Adams, Paul T., Gross, Howard M., Costantino, Joseph P., Paik, Soonmyung, Swain, Sandra M., Mamounas, Eleftherios P., Wolmark, Norman

“…Background NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary…”
Get full text

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer by BEAR, Harry D, GONG TANG, YOUNG, James A, SENECAL, Francis M, GAUR, Rakesh, MARGOLESE, Richard G, ADAMS, Paul T, GROSS, Howard M, COSTANTINO, Joseph P, SWAIN, Sandra M, MAMOUNAS, Eleftherios P, WOLMARK, Norman, RASTOGI, Priya, GEYER, Charles E, ROBIDOUX, André, ATKINS, James N, BAEZ-DIAZ, Luis, BRUFSKY, Adam M, MEHTA, Rita S, FEHRENBACHER, Louis

Get full text

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer by Bear, Harry D, Tang, Gong, Rastogi, Priya, Geyer, Charles E, Robidoux, Andre, Atkins, James N, Baez-Diaz, Luis, Brufsky, Adam M, Mehta, Rita S, Fehrenbacher, Louis, Young, James A, Senecal, Francis M, Gaur, Rakesh, Margolese, Richard G, Adams, Paul T, Gross, Howard M, Costantino, Joseph P, Swain, Sandra M, Mamounas, Eleftherios P, Wolmark, Normal

“…Neoadjuvant chemotherapy can increase the rates of breast-conserving surgery in patients with operable breast cancer and is a reasonable alternative to…”
Get full text

Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease by Dawson, Laura A, Saito, Naoyuki G, Ratanatharathorn, Voravit, Uberti, Joseph P, Adams, Paul T, Ayash, Lois J, Reynolds, Christopher M, Silver, Samuel M, Schipper, Matthew J, Lichter, Allen S, Eisbruch, Avraham

“…This Phase I study was designed to evaluate the tolerability of involved-field radiotherapy (IFRT) to areas of persistent disease in patients with high-risk…”
Get more information

Toxicity-Related Factors Associated With Use of Services Among Community Oncology Patients by Harrison, Jordan M, Stella, Philip J, LaVasseur, Beth, Adams, Paul T, Swafford, Lauren, Lewis, JoAnn, Mendelsohn-Victor, Kari, Friese, Christopher R

“…Community oncology practices frequently manage chemotherapy-associated toxicities, which may disrupt treatment, impair quality of life, and induce unplanned…”
Get full text

Factors associated with toxicity-related service use among community oncology patients by Harrison, Jordan M, Lavasseur, Beth, Stella, Philip J., Adams, Paul T., Swafford, Lauren, Lewis, JoAnn, Mendelsohn-Victor, Kari, Friese, Christopher Ryan

“…Abstract only 133 Background: Chemotherapy-associated toxicities occur often, yet sparse data are available to correlate toxicities with related service use…”
Get full text

Frequency and burden of patient-reported chemotherapy toxicities in community-based oncology practices by Friese, Christopher Ryan, Stella, Philip J., Lavasseur, Beth, Adams, Paul T., Swafford, Lauren, Lewis, JoAnn, Mendelsohn-Victor, Kari Michigan

“…Abstract only 178 Background: Patient-reported outcomes measurement is recommended to improve care delivery. Toxicities are important to study given their…”
Get full text

NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study by Leal, Alexis D., Qin, Rui, Atherton, Pamela J., Haluska, Paul, Behrens, Robert J., Tiber, Charles, Watanaboonyakhet, Patanit, Weiss, Matthias, Adams, Paul T., Dockter, Travis, Loprinzi, Charles L.

Get full text

Prediction and early detection of anthracycline-related cardiotoxicity using cardiac biomarkers by Stevens, Patrick Lawson, Lenihan, Daniel John, Ky, Bonnie, Warneke, Carla L., Johnson, Marcy M, Abramson, Vandana Gupta, Mayer, Ingrid A., Adams, Paul T., Campbell, Mark G., Cheema, Puneet S., Moore, Dennis Frederic, Yeshwant, Chilakamarri, Carver, Joseph R., Fisch, Michael

“…Abstract only…”
Get full text

Abstract PD2-1: The effect on overall and disease-free survival (OS & DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40 by Bear, Harry D, Tang, Gong, Rastogi, Priya, Geyer, Charles E, Liu, Qing, Robidoux, André, Atkins, James N, Baez-Diaz, Luis, Brufsky, Adam M, Mehta, Rita S, Fehrenbacher, Louis, Young, James A, Senecal, Francis M, Gaur, Rakesh, Margolese, Richard G, Adams, Paul T, Gross, Howard M, Costantino, Joseph P, Paik, Soonmyung, Swain, Sandra M, Mamounas, Eleftherios P, Wolmark, Norman

“…Abstract Purpose The NSABP B-40 study was designed to determine whether the addition of capecitabine (X) or gemcitabine (G) to neoadjuvant docetaxel (T)…”
Get full text

Use of diagnostic testing for patients with early-stage breast cancer in a multi-hospital quality collaborative in Michigan by Breslin, Tara M., Kubus, James, Ali, Haythem Y., Singh, T. Trevor, Adams, Paul T., Applewhite, Angela, Mehringer, Ann M., Silver, Samuel M.

“…Abstract only 242 Background: In 2012, ASCO identified five opportunities to improve the quality of cancer care and reduce costs. Two of these recommendations…”
Get full text

Clinical risk prediction in anthracycline cardiotoxicity by Ky, Bonnie, Warneke, Carla L., Lenihan, Daniel John, Cheema, Puneet S., Moore, Dennis Frederic, Campbell, Mark G., Yeshwant, Chilakamarri, Adams, Paul T., Krone, Ron, Carver, Joseph R., Nasta, Sunita, Svoboda, Jakub, Schuster, Stephen J., Reddy, Nishitha M., Patel, Sunil M., Rieber, Alyssa G., Johnson, Marcella M, Fisch, Michael

“…Abstract only…”
Get full text

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction by Datta, Y H, Adams, P T, Drobyski, W R, Ethier, S P, Terry, V H, Roth, M S

“…Detection of occult carcinoma in patients with breast cancer may aid the establishment of prognosis and development of new therapeutic approaches. To improve…”
Get more information

Detection of Circulating Donor White Blood Cells in Patients Receiving Multiple Transfusions by Adams, Paul T., Davenport, Robertson D., Reardon, David A., Roth, Mark S.

“…Significant morbidities are associated with the routine administration of blood products. Although the exact etiology of these complications may be unknown,…”
Get full text

In vitro expansion of hematopoietic cells for clinical application by Emerson, S G, Palsson, B O, Clarke, M F, Silver, S M, Adams, P T, Koller, M R, Van Zant, G, Rummel, S, Armstrong, R D, Maluta, J

Get more information